BioSpace News Archive

3D. The Red rocket that soars high and different than other rockets. Startup business successful concept.

Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical

The pending deal was rumored overnight after a report from the Financial Times, spurring analysts to speculate that if true, the entire gene editing space would see a boost at the markets.

June 17, 2025

·

3 min read

·

Annalee Armstrong

Brain shaped maze. Concept image of study and brain behavior.

Parkinson’s disease

Ventyx’s Parkinson’s Pill Shows ‘Promising’ Results in Mid-Stage Study, Paving Path to Other Neuro Diseases

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including Alzheimer’s.

June 17, 2025

·

2 min read

·

Tristan Manalac

Bureaucracy and administration management success with a group of tangled red tape and people running away on a pencil drawing line as a bureaucratic solution symbol with 3D illustration elements.

FDA

FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews

The program will bring together experts from across the FDA for a team-based review, rather than having an application move across numerous offices within the agency before getting a yay or nay.

June 17, 2025

·

2 min read

·

Annalee Armstrong

Composite photo collage of hands hold money income chip casino jackpot exchange poker game profit usd isolated on painted background.

Mergers & acquisitions

A String of Biopharma Deals Has Piqued Analyst Interest in an M&A Return

Big Pharma executives have not been shy about their desire for deals, but companies have been battling macro headwinds alongside Trump’s policies on drug pricing and tariff threats.

June 17, 2025

·

3 min read

·

Annalee Armstrong

CDC

CDC Scientist Resigns in Protest as Kennedy Reshapes Vaccine Regulation

HHS Secretary Robert F. Kennedy Jr.’s actions in recent months have raised concerns that he is taking a heavy-handed and unilateral approach to vaccine policy in the U.S.

June 17, 2025

·

2 min read

·

Tristan Manalac

Boston harbor and cityscape skyline view, Massachusetts, USA

Job Trends

$30M in Tax Incentives Fuel Job Growth: 1,500+ New Roles Coming to Massachusetts

Nearly $30 million in tax incentive awards are expected to add 1,519 new life sciences jobs in Massachusetts, with about 52% of the positions spread over Boston and Cambridge. Vertex, which received the largest award, will create hundreds of roles in Boston.

June 17, 2025

·

2 min read

·

Angela Gabriel

vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake

Cancer

Roche, AbbVie’s Venclexta Stumbles Again, This Time in Myelodysplastic Syndromes

Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic syndromes.

June 17, 2025

·

1 min read

·

Tristan Manalac

National Institutes of Health (NIH) building

Government

Court Orders Restoration of Canceled NIH Grants, Calls Cuts ‘Appalling’

District Judge William Young, a nominee of Republican President Ronald Reagan, blasted the Trump administration’s NIH cuts as discriminatory and “bearing down on people of color because of their color.”

June 17, 2025

·

2 min read

·

Tristan Manalac

Press Releases

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

June 17, 2025

·

6 min read

Press Releases

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease

June 17, 2025

·

7 min read